1. Home
  2. ARDX

as 07-01-2025 3:31pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Founded: 2007 Country:
United States
United States
Employees: N/A City: FREMONT
Market Cap: 885.2M IPO Year: 2014
Target Price: $10.17 AVG Volume (30 days): 4.6M
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.23 EPS Growth: N/A
52 Week Low/High: $3.21 - $8.06 Next Earning Date: 07-31-2025
Revenue: $361,706,000 Revenue Growth: 127.33%
Revenue Growth (this year): 12.01% Revenue Growth (next year): 34.66%

ARDX Daily Stock ML Predictions

Stock Insider Trading Activity of Ardelyx Inc. (ARDX)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
MOTT DAVID M ARDX Director Jun 16 '25 Buy $3.63 200,000 $725,880.00 2,896,871
MOTT DAVID M ARDX Director Jun 9 '25 Buy $3.69 200,000 $737,260.00 2,896,871
RAAB MICHAEL ARDX President & CEO May 20 '25 Sell $4.08 46,817 $191,078.90 1,547,937
Renz Justin A ARDX Chief Financial Officer May 20 '25 Sell $4.08 7,218 $29,459.55 416,089
Williams Laura A ARDX Chief Medical Officer May 20 '25 Sell $4.08 6,421 $26,206.67 402,583
Kelliher Mike ARDX See Remarks May 20 '25 Sell $4.08 14,522 $59,270.09 282,158
GRAMMER ELIZABETH A ARDX See Remarks May 20 '25 Sell $4.08 5,992 $24,455.75 311,731
Foster Eric Duane ARDX Chief Commercial Officer May 20 '25 Sell $4.08 2,507 $10,232.07 316,806
MOTT DAVID M ARDX Director May 15 '25 Buy $3.29 100,000 $329,120.00 2,896,871
MOTT DAVID M ARDX Director May 2 '25 Buy $4.22 381,377 $1,610,936.45 2,896,871

Share on Social Networks: